Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Hierarchical dynamics and time-length scale superposition in glassy suspensions of ultra-low crosslinked microgels.

The Journal of chemical physics·2026

Same author

Decoupling Structure and Elasticity in Colloidal Gels Under Isotropic Compression.

Physical review letters·2026

Same author

Corrigendum to: "Extreme ultraviolet transient gratings: A tool for nanoscale photoacoustics" [Photoacoustics 29 (2023) 100453].

Photoacoustics·2025

Same author

Erratum: Low-cost architecture for iron-based coated conductors.

iScience·2025

Same author

Low-cost architecture for iron-based coated conductors.

iScience·2024

Same author

The impact of face masks on face-to-face neural tracking of speech: Auditory and visual obstacles.

Heliyon·2024

Same journal

Screening of Medicinal and Edible Homology Substances for Diabetic Kidney Disease Based on GraphBAN.

Current medicinal chemistry·2026

Same journal

Berberine as an Antimicrobial Agent and Gut Microbiota Modulator: Mechanisms and Therapeutic Potential.

Current medicinal chemistry·2026

Same journal

Research Progress of Grapefruit-derived Extracellular Vesicles in Anti-tumor Treatment.

Current medicinal chemistry·2026

Same journal

Corrigendum to: Neuroprotective Mechanisms of Oxygen and Ethanol: A Potential Combination Therapy in Stroke.

Current medicinal chemistry·2026

Same journal

Ferroptosis and Its Crosstalk with Other Cell Death Modes in Ischemic Stroke.

Current medicinal chemistry·2026

Same journal

Integrative Analysis Reveals BPTF, COL1A1, and COL4A2 as Fibroblast-Related Biomarkers Associated with Immune Infiltration in Ovarian Cancer.

Current medicinal chemistry·2026

See all related articles

Search research articles

Related Experiment Video

Updated: May 23, 2026

Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis

Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis

Published on: June 9, 2018

Computational studies on transthyretin.

G Ortore¹, A Martinelli

¹Dipartimento di Scienze Farmaceutiche, Università di Pisa, Italy. ortore@farm.unipi.it

Current Medicinal Chemistry

|April 5, 2012

Summary

This summary is machine-generated.

Computational studies, including molecular dynamics and docking, are crucial for understanding transthyretin (TTR) aggregation in amyloidosis and designing effective inhibitors. This review details successful computational approaches and emerging trends for TTR-related amyloidosis research.

More Related Videos

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation

Published on: February 10, 2023

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging

Published on: July 14, 2016

Related Experiment Videos

Last Updated: May 23, 2026

Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis

Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis

Published on: June 9, 2018

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation

Published on: February 10, 2023

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging

Published on: July 14, 2016

Area of Science:

Biochemistry
Computational Biology
Medical Chemistry

Background:

Transthyretin (TTR) is implicated in the most common hereditary amyloidosis.
Extensive structural data and inhibitor studies exist, yet TTR aggregation mechanisms remain unclear.
Computational simulations offer a promising avenue for in-depth understanding.

Purpose of the Study:

To review computational studies on transthyretin aggregation and inhibition.
To provide insights into the mechanisms of TTR amyloidosis.
To rationalize the design of novel TTR fibril formation inhibitors.

Main Methods:

Molecular dynamics simulations
Molecular docking studies
Structure-activity relationship (SAR) analyses

Main Results:

Summary of key findings from computational simulations.
Identification of successful strategies for inhibiting TTR aggregation.
Highlighting of promising trends in computational drug design for TTR amyloidosis.

Conclusions:

Computational approaches are vital for elucidating TTR aggregation pathways.
These methods aid in the rational design of potent TTR amyloidosis inhibitors.
Future research should leverage advanced computational techniques for therapeutic development.